Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol IDH1 contributors: np/mct - updated : 30-05-2014
HGNC name isocitrate dehydrogenase 1 (NADP+), soluble
HGNC id 5382
ASSOCIATED DISORDERS
corresponding disease(s)
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral somatic mutation      
IDH1 mutations result in production of the onco-metabolite 2HG, contributing to the formation and malignant progression of gliomas
tumoral somatic mutation   --low  
downregulated in late-stage bladder cancers
tumoral somatic mutation     loss of function
homozygous G367A mutation in a case of anaplastic thyroid cancer resulting in a decreased enzymatic activity
tumoral somatic mutation      
heterozygous mutations occur in the majority of grade II and grade III gliomas and secondary glioblastomas
tumoral somatic mutation      
IDH1R132 may significantly add information regarding characterization and prognostication in acute myeloid leukemia
tumoral somatic mutation      
R132C substitution in enchondromatosis, Ollier disease and Maffucci disease (
tumoral somatic mutation      
R132H substitution in enchondromatosis, Ollier and Mafucci type
tumoral somatic mutation      
in chondrosarcoma
tumoral somatic mutation      
in giant cell tumor of bone
Susceptibility to familial early-onset generalised osteoarthritis
Variant & Polymorphism SNP
  • increasing the risk of familial early-onset generalised osteoarthritis
  • Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    metabolismamino acids 
    inhibiting endogenous IDH1/2 activity could be a novel medication for D2HA patients
    cancerendocrinethyroid
    potential tumorigenic role of IDH1 that could be a new therapeutic target for thyroid cancers
    ANIMAL & CELL MODELS